The FDA issued its first stamp of approval for a cell or gene therapy back in 2017 to Novartis' Kymriah. | The gene therapy ...
The new accelerated approval covers the use of Scemblix for newly diagnosed patients with Philadelphia chromosome-positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback